American International Group, Inc. Recursion Pharmaceuticals, Inc. Transaction History

American International Group, Inc.

$27.6 Billion
Q1 2024

A detailed history of American International Group, Inc. transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, American International Group, Inc. holds 68,660 shares of RXRX stock, worth $491,605. This represents 0.0% of its overall portfolio holdings.

Number of Shares

68,660

Previous 67,837 1.21%

Holding current value

$491,605

Previous $668,000 2.4%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$9.13 - $15.52 $7,513 - $12,772	823 Added 1.21%	68,660 $684,000
Q4 2023 Feb 13, 2024	SELL	$5.09 - $10.79 $1,399 - $2,967	-275 Reduced 0.4%	67,837 $668,000
Q3 2023 Nov 13, 2023	BUY	$6.59 - $15.86 $15,960 - $38,412	2,422 Added 3.69%	68,112 $521,000
Q2 2023 Aug 04, 2023	SELL	$4.56 - $9.94 $1,212 - $2,644	-266 Reduced 0.4%	65,690 $490,000
Q1 2023 May 12, 2023	BUY	$6.42 - $9.64 $8,416 - $12,638	1,311 Added 2.03%	65,956 $439,000

Q4 2022 Feb 10, 2023	SELL	$7.16 - $12.7 $1,682 - $2,984	-235 Reduced 0.36%	64,645 $498,000
Q3 2022 Nov 14, 2022	BUY	$7.83 - $13.6 $12,441 - $21,610	1,589 Added 2.51%	64,880 $690,000
Q2 2022 Aug 12, 2022	BUY	$5.04 - $9.26 $30,572 - $56,171	6,066 Added 10.6%	63,291 $515,000
Q1 2022 May 13, 2022	SELL	$6.16 - $18.03 $24,800 - $72,588	-4,026 Reduced 6.57%	57,225 $410,000
Q4 2021 Feb 11, 2022	BUY	$16.14 - $21.86 $740,035 - $1 Million	45,851 Added 297.73%	61,251 $1.05 Million
Q3 2021 Nov 12, 2021	BUY	$19.03 - $41.33 $67,765 - $147,176	3,561 Added 30.08%	15,400 $354,000
Q2 2021 Aug 13, 2021	BUY	$18.0 - $37.42 $213,102 - $443,015	11,839 New	11,839 $432,000

Others Institutions Holding RXRX

# of Institutions

260

Shares Held

192M

Call Options Held

787K

Put Options Held

1.52M

View Full List

About RECURSION PHARMACEUTICALS, INC.

Ticker RXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 180,480,000
Market Cap $1.29B
Description
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...

More about RXRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account

American International Group, Inc. Recursion Pharmaceuticals, Inc. Transaction History